Aberdeen Group’s Arvinas ARVN Stock Holding History

Aberdeen Group’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-78,585	Closed	-$1.51M	–	943
2024 Q4	$1.51M	Hold	78,585	–	–	﹤0.01%	783
2024 Q3	$1.94M	Buy	78,585 +17,093	+28%	+$446K	﹤0.01%	757
2024 Q2	$1.64M	Buy	+61,492	New	+$1.96M	﹤0.01%	770
2019 Q4	–	Sell	-19,801	Closed	-$427K	–	931
2019 Q3	$427K	Buy	+19,801	New	+$486K	﹤0.01%	872

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Aberdeen Group's ARVN Position: Q1 2025 in Review

Aberdeen Group sold out of Arvinas (ARVN) in Q1 2025, closing a stake of 78,585 shares — an estimated $1.51M sold.

Aberdeen Group first reported a position in ARVN in Q3 2019 and held it in 4 quarters. The position peaked at $1.94M in Q3 2024. 215 funds tracked by Wall St. Rank hold ARVN as of Q1 2025.

Aberdeen Group reported no remaining Arvinas position as of Q1 2025 after selling out during the quarter.
Aberdeen Group sold 78,585 Arvinas shares in Q1 2025, an estimated $1.51M.
Aberdeen Group first reported a position in Arvinas in Q3 2019 and held it in 4 quarters.
Aberdeen Group's Arvinas position peaked at $1.94M in Q3 2024.
215 funds tracked by Wall St. Rank held Arvinas as of Q1 2025.

Based on Aberdeen Group's 13F filing for Q1 2025, filed 13 May 2025.